(Q81201365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

A protocol for determination of anticardiolipin antibodies by ELISA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2

Eon Nigel Harris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Silvia S Pierangeli

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

840-848

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18451792%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nprot.2008.48

6 January 2020

exact match

0 references

cites work

Syndrome of the black swan

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Validation of the Sapporo criteria for antiphospholipid syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Revisiting the anticardiolipin test and its standardization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Consensus guidelines for anticardiolipin antibody testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Interlaboratory variation in antiphospholipid antibody testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis Among Patients With Systemic Lupus Erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies: clinical consequences of "low titers"

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Testing for antiphospholipid antibodies: problems and solutions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Assessing the variation in antiphospholipid antibody (APA) assays: comparison of results from 10 centers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiprothrombin antibodies--are they worth assaying?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Induction of antiphospholipid autoantibody during cytomegalovirus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Autoantibodies directed against phospholipids or human β 2 ‐glycoprotein 1 in HIV‐seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies in patients with infectious diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies in HIV infected patients with or without immune thrombocytopenic purpura

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies associated with HTLV-III infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Should anticardiolipin tests be performed in otherwise healthy pregnant women?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

A re-appraisal of the normal cut-off assignment for anticardiolipin IgM tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Characterization of anti-phosphatidylcholine polyreactive natural autoantibodies from normal human subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Lupus-like anticoagulant properties of murine monoclonal antibodies to beta 2-glycoprotein I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anti beta 2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibodies or not? The role of beta 2 glycoprotein 1 in autoantibody-mediated pregnancy loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Effects of repeated freeze-thaw cycles on anticardiolipin antibody immunoreactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of beta 2-glycoprotein-I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibodies differ in aPL cofactor requirement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Anomalous anticardiolipin antibody results may be due to cofactor variability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Clinical laboratory testing for the antiphospholipid syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48

IgG but not IgM anti-phospholipid antibody binding is temperature dependent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.48